Non-Alcoholic Fatty Liver Disease in Children: Current View on Diagnostics and Treatment (Part I)
Journal Title: Гастроентерологія - Year 2015, Vol 2, Issue 56
Abstract
Non-alcoholic fatty liver disease (NAFLD) is deemed to be the leading cause of chronic liver disease in children and adolescents in industrialized countries. NAFLD is associated with abdominal obesity, insulin resistance, carbohydrate intolerance and dyslipidemia; it is relative to metabolic syndrome and is its manifestation. Study data have shown that NAFLD has a higher overall mortality rate and high probability of developing cardiovascular disease, that is not dependent on the presence of classical risk factors of atherosclerosis. The monitoring of the course of the disease over the past 20 years has established a reduction in the duration of survival of patients with NAFLD compared with the expected rate in the general population, the progression of fibrosis in 80 % of cases, the development of decompensated forms of cirrhosis requires the transplantation in 6 % of patients. The tendency to progression of structural changes in the liver with the development of the terminal stages of the disease — cirrhosis and hepatocellular carcinoma, the risk of developing cardiovascular complications, possibility of preventing progredient course in timely therapeutic intervention necessitate early diagnosis of NAFLD in children. The leading constitutional risk factors of NAFLD that could be modified in the children are obesity and insulin resistance. The mechanism of NAFLD development and progression is a complex and multifactorial process. Nowadays there are two basic concepts that explain the pathogenesis of NAFLD — «two-hits» theory and «multiple parallel hits» theory. NAFLD in children has no specific clinical signs and is an accidental finding among asymptomatic patients. The manifestation of the disease occurs mostly over the age of 10 years old. There are nonspecific symptoms in the clinical picture of NAFLD in children — general weakness, rapid fatigability, exhaustion. Usually, the first step in the diagnosis of the disease is detection of elevated hepatic transaminases and/or sonographic signs of steatosis by routine clinical ultrasound. The diagnosis of NAFLD is possible in the absence of signs of liver injury of another nature, first of all autoimmune and drug-induced hepatitis.
Authors and Affiliations
Yu. M. Stepanov, А. Ye. Abaturov, N. Yu. Zavgorodnia, I. Yu. Skyrda
Keywords
Related Articles
- EP ID EP214684
- DOI -
- Views 58
- Downloads 0
Chronic pancreatitis: general principles of treatment
The literature review considers the problems of the treatment of abdominal pain syndrome, pancreatic exocrine insufficiency syndrome, chronic pancreatitis of Oddi’s sphincter dysfunction, disorders of gall bladder, bile...
Bacterial overgrowth syndrome in patients with chronic diffuse liver diseases depending on the etiology and morphological features
Background. Previous studies have shown an increased risk of liver disease in intestinal dysbiosis. Damage to the liver in itself can be the cause of the bacterial overgrowth syndrome. It has been proven that bacterial o...
State of Motor-Evacuation Function of the Stomach According to 13C-Octanoate Breath Test in Patients with Gastroesophageal Reflux Disease
We examined 58 patients with erosive form of gastroesophageal reflux disease and 10 healthy volunteers. All patients underwent fibrogastroduodenoscopy, 24 hour pH monitoring in the lower third of esophagus, 13C-octanoate...
Clinical Experience of Complex Application of Antiviral Therapy, Natural and Preformed Physical Factors in Patients with Chronic Hepatitis C
The article deals with the results of complex application of antiviral therapy, low-mineralized hydrocarbonate-sulphate-chloride sodium mineral water, EHF- and vibroacoustic therapy of the patients with chronic viral hep...
Assessment of Quality of Life in Patients with Combination of Nonalcoholic Fatty Liver Disease and Stable Forms of Coronary Heart Disease
The article presents the results of assessment of the quality of life in patients with isolated nonalcoholic fatty liver disease and in combination with stable forms of coronary heart disease. Quality of life was evaluat...